Get startedLog in
    Picture of COSCIENS Biopharma logo

    CSCI — COSCIENS Biopharma Cashflow Statement

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareAdventurousMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for COSCIENS Biopharma, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

    2020
    December 31st
    2021
    December 31st
    2022
    December 31st
    R2023
    December 31st
    2024
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line-5.12-8.37-22.7-3.48-15.3
    Depreciation
    Non-Cash Items-0.197-1.257.48-0.6930.905
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital0.9540.8951.440.153-1.77
    Change in Accounts Receivable
    Change in Inventories
    Change in Prepaid Expenses
    Change in Payable / Accrued Expenses
    Change in Taxes Payable
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities-4.13-8.58-13.7-2.58-14.6
    Capital Expenditures—-0.639-0.011-0.722-1.16
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items0.056-0.019-0.001-0.00826.2
    Sale of Business
    Sale of Fixed Assets
    Other Investing Cash Flow
    Cash from Investing Activities0.056-0.658-0.012-0.7325.1
    Financing Cash Flow Items-2.77-3.120.016——
    Other Financing Cash Flow
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities20.551-0.118-0.357-0.588
    Foreign Exchange Effects
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash16.441-14.7-3.519.71